ロード中...

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells

Resistance to chemotherapy and a high relapse rate highlight the importance of finding new therapeutic options for the treatment of acute myeloid leukemia (AML). Histone deacetylase (HDAC) inhibitors (HDACIs) are a promising class of drugs for the treatment of AML. HDACIs have limited single-agent c...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Zhao, Jianyun, Xie, Chengzhi, Edwards, Holly, Wang, Guan, Taub, Jeffrey W, Ge, Yubin
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351634/
https://ncbi.nlm.nih.gov/pubmed/28030834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14062
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!